Precision BioSciences, Inc.
DTIL
$4.62
-$0.13-2.74%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -20.57M | -17.75M | -16.43M | 32.75M | 8.59M |
| Total Depreciation and Amortization | 705.00K | 757.00K | 1.01M | 1.38M | 1.43M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.10M | -2.60M | -397.00K | -4.53M | -8.67M |
| Change in Net Operating Assets | -1.30M | 901.00K | 9.90M | -44.47M | -20.33M |
| Cash from Operations | -19.05M | -18.68M | -5.91M | -14.87M | -18.98M |
| Capital Expenditure | -64.00K | -97.00K | -39.00K | -28.00K | -86.00K |
| Sale of Property, Plant, and Equipment | -- | 0.00 | 0.00 | 0.00 | 60.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -250.00K | 0.00 | -25.00K | -- | -- |
| Cash from Investing | -314.00K | -97.00K | -64.00K | -28.00K | -26.00K |
| Total Debt Issued | -- | -20.00K | 22.49M | -- | -- |
| Total Debt Repaid | -- | 0.00 | -22.51M | -- | -- |
| Issuance of Common Stock | 10.69M | 5.94M | 3.75M | 702.00K | 40.10M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10.69M | 5.92M | 3.73M | 702.00K | 40.10M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -8.68M | -12.86M | -2.24M | -14.20M | 21.09M |